{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:17:37Z","timestamp":1794881857275,"version":"4.9.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gastrohep.2026.502916","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:11:15Z","timestamp":1792451475000},"page":"502916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seguridad farmacoterap\u00e9utica en el paciente con cirrosis hep\u00e1tica: encuesta nacional multidisciplinar sobre recursos y necesidades percibidas"],"prefix":"10.1016","author":[{"given":"Andrea","family":"Rodr\u00edguez Esqu\u00edroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Echeverr\u00eda Gorriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garj\u00f3n Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Aguinaga Ontoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2026.502916_bib0100","first-page":"726","article-title":"\u00c9pid\u00e9miologie de la cirrhose: Une augmentation d\u2019incidence attendue en lien avec l\u2019\u00e9pid\u00e9miologie du diab\u00e8te et de l\u2019ob\u00e9sit\u00e9","volume":"67","author":"Ganne-Carri\u00e9","year":"2017","journal-title":"Rev Prat."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40261-022-01150-w","article-title":"Management of Pharmacologic Adverse Effects in Advanced Liver Disease","volume":"42","author":"Garc\u00eda-Cort\u00e9s","year":"2022","journal-title":"Clin Drug Investig."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/antibiotics11010031","article-title":"Antibiotics and Liver Cirrhosis: What the Physicians Need to Know","volume":"11","author":"Zoratti","year":"2021","journal-title":"Antibiotics."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0120","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40261-023-01289-0","article-title":"Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature Review","volume":"43","author":"Karsten Dafonte","year":"2023","journal-title":"Clin Drug Investig."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0125","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00228-013-1502-z","article-title":"Dose adjustment in patients with liver cirrhosis: Impact on adverse drug reactions and hospitalizations","volume":"69","author":"Franz","year":"2013","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0130","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/hep.31548","article-title":"Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis","volume":"73","author":"Thomson","year":"2021","journal-title":"Hepatology."},{"issue":"11\u201312","key":"10.1016\/j.gastrohep.2026.502916_bib0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s40267-025-01200-1","article-title":"Identification of Potential Drug\u2013Disease Interactions in Hospitalized Patients with Liver Cirrhosis and the Prospective Utility of Clinical Decision Support Alerts","volume":"41","author":"Wuyts","year":"2025","journal-title":"Drugs Ther Perspect."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0140","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.cgh.2016.04.009","article-title":"Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study","volume":"14","author":"Tapper","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S2468-1253(17)30362-X","article-title":"Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England","volume":"3","author":"Hudson","year":"2018","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0150","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032608","article-title":"Prevalence and global trends of polypharmacy in patients with chronic liver disease: A systematic review and meta-analysis","volume":"102","author":"Danjuma","year":"2023","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0155","unstructured":"Centro de informaci\u00f3n online de medicamentos de la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Buscador para profesionales sanitarios. [consultado 18 May 2026]. Disponible en: https:\/\/cima.aemps.es\/cima\/publico\/buscadoravanzado.html."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2019.01031","article-title":"Evaluation of information in summaries of product characteristics (SmPCs) on the use of a medicine in patients with hepatic impairment","volume":"10","author":"Weersink","year":"2019","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0165","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/bcp.14177","article-title":"Medication safety in patients with hepatic impairment: A survey of community pharmacists\u2019 knowledge level and their practice in caring for these patients","volume":"86","author":"Weersink","year":"2020","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0170","year":"2018"},{"key":"10.1016\/j.gastrohep.2026.502916_bib0175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40264-018-0744-1","article-title":"Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study","volume":"42","author":"Weersink","year":"2019","journal-title":"Drug Saf."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13722-022-00292-8","article-title":"Clinicians\u2019 perspectives and perceived barriers to caring for patients with alcohol use disorder and cirrhosis","volume":"17","author":"Johnson","year":"2022","journal-title":"Addict Sci Clin Pract."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3138\/canlivj-2022-0036","article-title":"The development and evaluation of a provider-focused educational intervention about alcohol use disorder in patients with cirrhosis","volume":"6","author":"Johnson","year":"2023","journal-title":"Can Liver J."},{"key":"10.1016\/j.gastrohep.2026.502916_bib0190","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40261-026-01536-0","article-title":"Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert Panel","volume":"46","author":"Karsten Dafonte","year":"2026","journal-title":"Clin Drug Investig."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057052601006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057052601006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:29:15Z","timestamp":1794878955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021057052601006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"alternative-id":["S021057052601006X"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2026.502916","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seguridad farmacoterap\u00e9utica en el paciente con cirrosis hep\u00e1tica: encuesta nacional multidisciplinar sobre recursos y necesidades percibidas","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2026.502916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502916"}}